FindTrial
Sign In

Interventional treatment for cesarean scar pregnancy

Clinical research on the treatment of cesarean scar pregnancy with drug therapy combined with uterine curettage under ultrasound intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125331
Enrollment
Unknown
Registered
2026-05-25
Start date
2026-05-25
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean scar pregnancy

Interventions

Low methotrexate 75 mg and Polidocanol > 5 ml group:None
Methotrexate > 75 mg and Polidocanol <= 5 ml group:None

Sponsors

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Previous history of cesarean section, positive HCG, gestational age =12 weeks; 2.Meet the clinical diagnosis and ultrasound diagnostic criteria of CSP;

Exclusion criteria

Exclusion criteria: 1.There is massive vaginal bleeding and uterine rupture. 2. Combined with severe cardiopulmonary function diseases; 3.There are contraindications for the surgery in this study. All the included patients signed the informed consent form.

Design outcomes

Primary

MeasureTime frame
Dosage of methotrexate;Maximum diameter of CSP;—

Secondary

MeasureTime frame
The time interval from the last cesarean section to scar pregnancy;—

Countries

China

Contacts

Public ContactWang Jun

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

647875039@qq.com+86 472 2178661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026